Core Insights - New to The Street is a prominent financial media brand that broadcasts weekly on Bloomberg Television and Fox Business, reaching millions of households across the U.S., Latin America, and MENA regions [6] Group 1: Featured Companies - FreeCast (NASDAQ:CAST) is transforming digital media aggregation and streaming access for consumers worldwide [3] - KLED.ai is advancing AI-driven enterprise and data intelligence solutions [3] - Lantern Pharma (NASDAQ:LTRN) is a leader in AI-powered oncology drug development [3] - BlackBarn Restaurant is a premier culinary destination in New York City known for its farm-to-table excellence [3] - Virtuix (NASDAQ:VRTX) specializes in immersive virtual reality technology [4] - NRx Pharmaceuticals (NASDAQ:NRXP) focuses on advanced therapeutics for critical conditions [4] - PetVivo Holdings is involved in veterinary regenerative medicine [4] - DataVault AI (NASDAQ:DVLT) provides data monetization and tokenization infrastructure [4] - Roadzen (NASDAQ:RDZN) offers an AI-powered insurance and mobility platform [4] - Stardust Power (NASDAQ:SDST) is engaged in lithium and energy infrastructure solutions [4] - CISO Global (NASDAQ:CISO) is an enterprise cybersecurity leader [4] - The Sustainable Green Team (OTC:SGTM) focuses on climate and sustainable infrastructure solutions [4] Group 2: Media Reach and Impact - New to The Street has a combined platform reach exceeding 5.1 million subscribers, including 4.44 million on its YouTube channel and over 700,000 on the NewsOut Digital Network [4][5] - The platform utilizes various distribution channels, including LinkedIn, X, Instagram, and Facebook, along with iconic billboard placements in Times Square and NYC's Financial District [4] - New to The Street continues to outperform traditional financial media platforms in terms of reach, engagement, and measurable impact, establishing itself as a dominant force in next-generation financial media [5]

Company Overview - Elanco Animal Health Incorporated (NYSE:ELAN) specializes in veterinary medicine, providing products for the protection and treatment of pets and farm animals, including parasiticides, vaccines, therapeutics, and medicated feed additives [3]. Stock Performance - The stock has shown a remarkable performance, increasing by 137% over the past 12 months and nearly 17% since the beginning of 2026 [1]. - Following a strong quarterly report, Elanco's stock rose by 6.6% [1]. Financial Highlights - The company reported a 12% revenue growth, attributed to strong performance in both pet health and farm animal segments [1]. - Elanco achieved a 2-cent earnings beat, reporting earnings of 11 cents per share [1]. - Management provided a solid full-year forecast, indicating confidence in continued growth [1][2]. Management and Strategy - The management has successfully turned the company around, demonstrating effective strategies that have impressed analysts [2].

Core Viewpoint - The article highlights the remarkable career and contributions of Xu Huizao, a leading figure in the field of veterinary ophthalmology in China, emphasizing his dedication to animal health and education, as well as the legacy of his family in veterinary medicine [3][4][10]. Group 1: Professional Achievements - Xu Huizao is recognized as a pioneer in animal ophthalmology, having performed the first penetrating corneal transplant surgery on dogs in China in 2007, which laid the groundwork for further advancements in the field [6][7]. - In 2018, he achieved a significant milestone by successfully using bioengineered corneal transplant technology for treating corneal diseases in dogs, cats, and wild animals, marking a breakthrough in veterinary ophthalmology [9][10]. - Xu has been awarded multiple honors, including the "Outstanding Technical Achievement Award" from the Chinese Society of Animal Husbandry and Veterinary Medicine, and has led his team to win the top prize in the "Eagle Cup" veterinary skills competition seven times, maintaining a national record [10]. Group 2: Educational Contributions - Xu Huizao has established the first course on small animal ophthalmology in domestic universities and has been actively involved in clinical research and teaching, contributing to the education of future veterinarians [7][10]. - He has taken initiatives to provide hands-on experience for students by fostering a learning environment that includes caring for stray animals and engaging them in clinical research [10]. - His mentorship has significantly impacted his students' careers, with many achieving notable positions in the veterinary field shortly after graduation [10]. Group 3: Family Legacy - Xu Huizao is the third generation in his family to work in veterinary medicine, following in the footsteps of his grandfather and father, both of whom made significant contributions to the field [4][5]. - His grandfather, a military veterinarian, and his father, a clinical veterinary expert, have both played pivotal roles in advancing veterinary education and practice in China [4][5]. - This family legacy underscores the importance of tradition and continuity in the veterinary profession, with Xu Huizao committed to upholding these values in his work [10].

Industry Trend - Cases of flesh-eating screwworm are on the rise in Mexico [1]

Ready-made stem cell therapies for pets could be coming | TechCrunch https://t.co/ukOEqmlBkX ...